Decision Analysis for Use of Platelet Aggregation Test, Carbon 14–Serotonin Release Assay, and Heparin–Platelet Factor 4 Enzyme-Linked Immunosorbent Assay for Diagnosis of Heparin-lnduced Thrombocytopenia
Authors:
Open Access
- 1 May 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 111 (5) , 700-706
Abstract
The value of the platelet aggregation test, carbon 14–labeled serotonin release assay (SRA), and heparin–platelet factor 4 enzyme-linked immunosorbent assay (H-PF4 ELISA)for the diagnosis of heparin-induced thrombocytopenia was evaluated by studying blood samples from 100 patients with suspected heparin-induced thrombocytopenia, and categorized into 4 clinical groups: unlikely (n = 22), possible (34), probable (36), and definite (8) thrombocytopenia. Results of the platelet aggregation test were positive in 40 of 44 patients with probable or definite heparin-induced thrombocytopenia (sensitivity 91%) and in 5 of 22 unlikely to have heparin-induced thrombocytopenia (specificity 77%). The SRA exhibited sensitivity of 88% and negative predictive value of 81%, close to those values for the platelet aggregation test; specificity and positive predictive value were 100%. The sensitivity of the heparin-PF4 EL1SA was 97%, with specificity 86%, and a positive correlation was recorded between the level of antibodies to H-PF4 and clinical score (P = 0.66). When ELISA was used with the platelet aggregation test or SRA, positive predictive value and specificity were 100% when both tests yielded positive results, and negative predictive value was 100% when both tests yielded negative results. A biologic flow chart was designed that presented a choice based on the results of the platelet aggregation test or SRA in association with ELISA, and enabled more accurate and specific identification of heparin-induced thrombocytopenia.Keywords
This publication has 13 references indexed in Scilit:
- Differences in specificity of heparin‐dependent antibodies developed in heparin‐induced thrombocytopenia and consequences on cross‐reactivity with danaparoid sodiumBritish Journal of Haematology, 1997
- A 14-year study of heparin-induced thrombocytopeniaThe American Journal of Medicine, 1996
- Comparison of PF4/Heparin ELISA Assay With the14C-Serotonin Release Assay in the Diagnosis of Heparin-induced ThrombocytopeniaAmerican Journal of Clinical Pathology, 1995
- Antibodies to Macromolecular Platelet Factor 4-Heparin Complexes in Heparin-induced Thrombocytopenia: a Study of 44 CasesThrombosis and Haemostasis, 1995
- Laboratory diagnosis of heparin‐associated thrombocytopenia and comparison of platelet aggregation test, heparin‐induced platelet activation test, and platelet factor 4/heparin enzyme‐linked immunosorbent assayTransfusion, 1994
- The Clinical Usefulness of the Platelet Aggregation Test for the Diagnosis of Heparin-Induced ThrombocytopeniaThrombosis and Haemostasis, 1993
- Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced ThrombocytopeniaThrombosis and Haemostasis, 1992
- A Rapid and Sensitive Test for Diagnosing Heparin-Associated ThrombocytopeniaThrombosis and Haemostasis, 1991
- Different platelet specificities of heparin‐dependent platelet aggregating factors in heparin‐associated immune thrombocytopeniaBritish Journal of Haematology, 1986
- Treatment of Heparin-Associated Thrombocytopenia and Thrombosis with Low Molecular Weight Heparin (CY 216)Seminars in Thrombosis and Hemostasis, 1985